Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib

Abstract In the current era of immune therapy, lenvatinib (LEN) continues to be vital for treating unresectable hepatocellular carcinoma (uHCC) patients. This study investigates the importance of nutritional status in the prognosis of uHCC patients receiving LEN and evaluates a new prognostic scorin...

Full description

Saved in:
Bibliographic Details
Main Authors: Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hironori Tanaka, Hiroki Nishikawa, Hiroshi Shibata, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa, Takashi Kumada
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-78539-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559779743367168
author Hideko Ohama
Atsushi Hiraoka
Toshifumi Tada
Masashi Hirooka
Kazuya Kariyama
Joji Tani
Masanori Atsukawa
Koichi Takaguchi
Ei Itobayashi
Shinya Fukunishi
Kunihiko Tsuji
Toru Ishikawa
Kazuto Tajiri
Hironori Ochi
Satoshi Yasuda
Hidenori Toyoda
Chikara Ogawa
Takashi Nishimura
Takeshi Hatanaka
Satoru Kakizaki
Noritomo Shimada
Kazuhito Kawata
Atsushi Naganuma
Hisashi Kosaka
Tomomitsu Matono
Hidekatsu Kuroda
Yutaka Yata
Hironori Tanaka
Hiroki Nishikawa
Hiroshi Shibata
Fujimasa Tada
Kazuhiro Nouso
Asahiro Morishita
Akemi Tsutsui
Takuya Nagano
Norio Itokawa
Tomomi Okubo
Taeang Arai
Michitaka Imai
Yohei Koizumi
Shinichiro Nakamura
Hiroko Iijima
Masaki Kaibori
Yoichi Hiasa
Takashi Kumada
author_facet Hideko Ohama
Atsushi Hiraoka
Toshifumi Tada
Masashi Hirooka
Kazuya Kariyama
Joji Tani
Masanori Atsukawa
Koichi Takaguchi
Ei Itobayashi
Shinya Fukunishi
Kunihiko Tsuji
Toru Ishikawa
Kazuto Tajiri
Hironori Ochi
Satoshi Yasuda
Hidenori Toyoda
Chikara Ogawa
Takashi Nishimura
Takeshi Hatanaka
Satoru Kakizaki
Noritomo Shimada
Kazuhito Kawata
Atsushi Naganuma
Hisashi Kosaka
Tomomitsu Matono
Hidekatsu Kuroda
Yutaka Yata
Hironori Tanaka
Hiroki Nishikawa
Hiroshi Shibata
Fujimasa Tada
Kazuhiro Nouso
Asahiro Morishita
Akemi Tsutsui
Takuya Nagano
Norio Itokawa
Tomomi Okubo
Taeang Arai
Michitaka Imai
Yohei Koizumi
Shinichiro Nakamura
Hiroko Iijima
Masaki Kaibori
Yoichi Hiasa
Takashi Kumada
author_sort Hideko Ohama
collection DOAJ
description Abstract In the current era of immune therapy, lenvatinib (LEN) continues to be vital for treating unresectable hepatocellular carcinoma (uHCC) patients. This study investigates the importance of nutritional status in the prognosis of uHCC patients receiving LEN and evaluates a new prognostic scoring system that combines the geriatric nutritional risk index (GNRI) and systemic inflammatory response. From 2018 to 2022, 484 uHCC patients treated with LEN (384 males, median age 73). Prognostic value was compared between GNRI and C-reactive protein (CRP) scoring (GNRI-C score), GNRI, and neo-Glasgow prognostic score (neo-GPS). Evaluation was based on the Akaike information criterion (AIC) and concordance index(c-index). Median progression-free survival (mPFS) was 9.3/6.8/4.6 months for GNRI no-risk/low-risk/moderate-to-major risk (p < 0.01, AIC 4742.4/c-index 0.585). Median overall survival (mOS) was 27.8/15.2/9.5 months (p < 0.01, AIC 3433.34/c-index 0.639). For GNRI-C score, mPFS was 10.8/7.1/5.6/4.0 months (score 0/1/2/3) (p < 0.01, AIC 4732.82/c-index 0.6), while neo-GPS showed mPFS of 8.5/5.1/5.2 months (p < 0.01, AIC 4745.89/c-index 0.562). For mOS, GNRI-C score demonstrated 28.6/20.0/10.1/8.4 months (score 0/1/2/3) (p < 0.01, AIC 3420.27/c-index 0.652), while neo-GPS indicated 21.0/12.4/4.5 months (p < 0.01, AIC 3468.84/c-index 0.564). The newly devised GNRI-C score, incorporating nutritional and inflammatory markers, could offer improved prognostic predictions for uHCC patients treated with LEN.
format Article
id doaj-art-f8113088e2dd4e0f9d096e01939c07d3
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-f8113088e2dd4e0f9d096e01939c07d32025-01-05T12:13:59ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-024-78539-4Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinibHideko Ohama0Atsushi Hiraoka1Toshifumi Tada2Masashi Hirooka3Kazuya Kariyama4Joji Tani5Masanori Atsukawa6Koichi Takaguchi7Ei Itobayashi8Shinya Fukunishi9Kunihiko Tsuji10Toru Ishikawa11Kazuto Tajiri12Hironori Ochi13Satoshi Yasuda14Hidenori Toyoda15Chikara Ogawa16Takashi Nishimura17Takeshi Hatanaka18Satoru Kakizaki19Noritomo Shimada20Kazuhito Kawata21Atsushi Naganuma22Hisashi Kosaka23Tomomitsu Matono24Hidekatsu Kuroda25Yutaka Yata26Hironori Tanaka27Hiroki Nishikawa28Hiroshi Shibata29Fujimasa Tada30Kazuhiro Nouso31Asahiro Morishita32Akemi Tsutsui33Takuya Nagano34Norio Itokawa35Tomomi Okubo36Taeang Arai37Michitaka Imai38Yohei Koizumi39Shinichiro Nakamura40Hiroko Iijima41Masaki Kaibori42Yoichi Hiasa43Takashi Kumada44Gastroenterology Center, Ehime Prefectural Central HospitalGastroenterology Center, Ehime Prefectural Central HospitalDepartment of Internal Medicine, Japanese Red Cross Himeji HospitalDepartment of Gastroenterology and Metabology, Ehime University Graduate School of MedicineDepartment of Gastroenterology, Okayama City HospitalDepartment of Gastroenterology and Neurology, Kagawa UniversityDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical SchoolDepartment of Hepatology, Kagawa Prefectural Central HospitalDepartment of Gastroenterology, Asahi General HospitalDepartment of Gastroenterology, Hyogo Medical UniversityCenter for Gastroenterology, Teine Keijinkai HospitalDepartment of Gastroenterology, Saiseikai Niigata HospitalDepartment of Gastroenterology, Toyama University HospitalCenter for Liver- Biliary- Pancreatic Disease, Matsuyama Red Cross HospitalDepartment of Gastroenterology and Hepatology, Ogaki Municipal HospitalDepartment of Gastroenterology and Hepatology, Ogaki Municipal HospitalDepartment of Gastroenterology, Japanese Red Cross Takamatsu HospitalDepartment of Gastroenterology, Hyogo Medical UniversityDepartment of Gastroenterology, Gunma Saiseikai Maebashi HospitalDepartment of Clinical Research, NHO Takasaki General Medical CenterDivision of Gastroenterology and Hepatology, Otakanomori HospitalHepatology Division, Department of Internal Medicine II, Hamamatsu University School of MedicineDepartment of Gastroenterology, NHO Takasaki General Medical CenterDepartment of Hepatobiliary Surgery, Kansai Medical UniversityDepartment of Gastroenterology, Hyogo Prefectural Harima-Himeji General Medical CenterDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, School of MedicineDepartment of Gastroenterology, Hanwa Memorial HospitalDepartment of Gastroenterology, Takarazuka City HospitalDepartment of Gastroenterology, Osaka Medical and Pharmaceutical UniversityDepartment of Gastroenterology, Tokushima Prefectural Central HospitalGastroenterology Center, Ehime Prefectural Central HospitalDepartment of Gastroenterology, Okayama City HospitalDepartment of Gastroenterology and Neurology, Kagawa UniversityDepartment of Hepatology, Kagawa Prefectural Central HospitalDepartment of Hepatology, Kagawa Prefectural Central HospitalDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical SchoolDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical SchoolDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical SchoolDepartment of Gastroenterology, Saiseikai Niigata HospitalDepartment of Gastroenterology and Metabology, Ehime University Graduate School of MedicineDepartment of Internal Medicine, Japanese Red Cross Himeji HospitalDepartment of Gastroenterology, Hyogo Medical UniversityDepartment of Hepatobiliary Surgery, Kansai Medical UniversityDepartment of Gastroenterology and Metabology, Ehime University Graduate School of MedicineDepartment of Nursing, Gifu Kyoritsu UniversityAbstract In the current era of immune therapy, lenvatinib (LEN) continues to be vital for treating unresectable hepatocellular carcinoma (uHCC) patients. This study investigates the importance of nutritional status in the prognosis of uHCC patients receiving LEN and evaluates a new prognostic scoring system that combines the geriatric nutritional risk index (GNRI) and systemic inflammatory response. From 2018 to 2022, 484 uHCC patients treated with LEN (384 males, median age 73). Prognostic value was compared between GNRI and C-reactive protein (CRP) scoring (GNRI-C score), GNRI, and neo-Glasgow prognostic score (neo-GPS). Evaluation was based on the Akaike information criterion (AIC) and concordance index(c-index). Median progression-free survival (mPFS) was 9.3/6.8/4.6 months for GNRI no-risk/low-risk/moderate-to-major risk (p < 0.01, AIC 4742.4/c-index 0.585). Median overall survival (mOS) was 27.8/15.2/9.5 months (p < 0.01, AIC 3433.34/c-index 0.639). For GNRI-C score, mPFS was 10.8/7.1/5.6/4.0 months (score 0/1/2/3) (p < 0.01, AIC 4732.82/c-index 0.6), while neo-GPS showed mPFS of 8.5/5.1/5.2 months (p < 0.01, AIC 4745.89/c-index 0.562). For mOS, GNRI-C score demonstrated 28.6/20.0/10.1/8.4 months (score 0/1/2/3) (p < 0.01, AIC 3420.27/c-index 0.652), while neo-GPS indicated 21.0/12.4/4.5 months (p < 0.01, AIC 3468.84/c-index 0.564). The newly devised GNRI-C score, incorporating nutritional and inflammatory markers, could offer improved prognostic predictions for uHCC patients treated with LEN.https://doi.org/10.1038/s41598-024-78539-4Hepatocellular carcinomaLenvatinibGNRICRPGNRI-C
spellingShingle Hideko Ohama
Atsushi Hiraoka
Toshifumi Tada
Masashi Hirooka
Kazuya Kariyama
Joji Tani
Masanori Atsukawa
Koichi Takaguchi
Ei Itobayashi
Shinya Fukunishi
Kunihiko Tsuji
Toru Ishikawa
Kazuto Tajiri
Hironori Ochi
Satoshi Yasuda
Hidenori Toyoda
Chikara Ogawa
Takashi Nishimura
Takeshi Hatanaka
Satoru Kakizaki
Noritomo Shimada
Kazuhito Kawata
Atsushi Naganuma
Hisashi Kosaka
Tomomitsu Matono
Hidekatsu Kuroda
Yutaka Yata
Hironori Tanaka
Hiroki Nishikawa
Hiroshi Shibata
Fujimasa Tada
Kazuhiro Nouso
Asahiro Morishita
Akemi Tsutsui
Takuya Nagano
Norio Itokawa
Tomomi Okubo
Taeang Arai
Michitaka Imai
Yohei Koizumi
Shinichiro Nakamura
Hiroko Iijima
Masaki Kaibori
Yoichi Hiasa
Takashi Kumada
Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
Scientific Reports
Hepatocellular carcinoma
Lenvatinib
GNRI
CRP
GNRI-C
title Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
title_full Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
title_fullStr Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
title_full_unstemmed Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
title_short Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
title_sort geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
topic Hepatocellular carcinoma
Lenvatinib
GNRI
CRP
GNRI-C
url https://doi.org/10.1038/s41598-024-78539-4
work_keys_str_mv AT hidekoohama geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT atsushihiraoka geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT toshifumitada geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT masashihirooka geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT kazuyakariyama geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT jojitani geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT masanoriatsukawa geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT koichitakaguchi geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT eiitobayashi geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT shinyafukunishi geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT kunihikotsuji geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT toruishikawa geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT kazutotajiri geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hironoriochi geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT satoshiyasuda geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hidenoritoyoda geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT chikaraogawa geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT takashinishimura geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT takeshihatanaka geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT satorukakizaki geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT noritomoshimada geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT kazuhitokawata geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT atsushinaganuma geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hisashikosaka geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT tomomitsumatono geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hidekatsukuroda geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT yutakayata geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hironoritanaka geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hirokinishikawa geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hiroshishibata geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT fujimasatada geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT kazuhironouso geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT asahiromorishita geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT akemitsutsui geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT takuyanagano geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT norioitokawa geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT tomomiokubo geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT taeangarai geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT michitakaimai geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT yoheikoizumi geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT shinichironakamura geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT hirokoiijima geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT masakikaibori geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT yoichihiasa geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib
AT takashikumada geriatricnutritionalriskindexandnewlydevelopedscoringsystemasprognosispredictionforunresectablehepatocellularcarcinomapatientstreatedwithlenvatinib